News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
782,306 Results
Type
Article (60490)
Company Profile (359)
Press Release (721442)
Multimedia
Podcasts (119)
Webinars (19)
Section
Business (218208)
Career Advice (2627)
Deals (37752)
Drug Delivery (130)
Drug Development (86554)
Employer Resources (180)
FDA (17643)
Job Trends (16268)
News (370931)
Policy (36234)
Tag
Academia (2940)
Accelerated approval (18)
Adcomms (33)
Allergies (124)
Alliances (53696)
ALS (146)
Alzheimer's disease (1657)
Antibody-drug conjugate (ADC) (242)
Approvals (17695)
Artificial intelligence (447)
Autoimmune disease (77)
Automation (27)
Bankruptcy (382)
Best Places to Work (12374)
BIOSECURE Act (21)
Biosimilars (157)
Biotechnology (233)
Bladder cancer (134)
Brain cancer (52)
Breast cancer (508)
Cancer (3974)
Cardiovascular disease (330)
Career advice (2212)
Career pathing (37)
CAR-T (239)
CDC (51)
Cell therapy (642)
Cervical cancer (33)
Clinical research (72019)
Collaboration (1387)
Company closure (4)
Compensation (927)
Complete response letters (56)
COVID-19 (2918)
CRISPR (79)
C-suite (587)
Cystic fibrosis (138)
Data (4585)
Decentralized trials (2)
Denatured (43)
Depression (109)
Diabetes (442)
Diagnostics (6933)
Digital health (35)
Diversity (11)
Diversity, equity & inclusion (47)
Drug discovery (202)
Drug pricing (182)
Drug shortages (34)
Duchenne muscular dystrophy (200)
Earnings (92251)
Editorial (53)
Employer branding (22)
Employer resources (159)
Events (123965)
Executive appointments (977)
FDA (20128)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (1254)
Gene editing (170)
Generative AI (38)
Gene therapy (523)
GLP-1 (978)
Government (5103)
Grass and pollen (7)
Guidances (351)
Healthcare (20532)
HIV (45)
Huntington's disease (37)
IgA nephropathy (64)
Immunology and inflammation (234)
Immuno-oncology (20)
Indications (53)
Infectious disease (3159)
Inflammatory bowel disease (186)
Inflation Reduction Act (14)
Influenza (97)
Intellectual property (187)
Interviews (445)
IPO (17460)
IRA (53)
Job creations (4269)
Job search strategy (1858)
Kidney cancer (17)
Labor market (73)
Layoffs (597)
Leadership (34)
Legal (8878)
Liver cancer (91)
Longevity (13)
Lung cancer (575)
Lymphoma (267)
Machine learning (30)
Management (62)
Manufacturing (618)
MASH (138)
Medical device (14776)
Medtech (14801)
Mergers & acquisitions (21171)
Metabolic disorders (1121)
Multiple sclerosis (136)
NASH (21)
Neurodegenerative disease (222)
Neuropsychiatric disorders (58)
Neuroscience (2679)
NextGen: Class of 2025 (7267)
Non-profit (4967)
Now hiring (58)
Obesity (540)
Opinion (300)
Ovarian cancer (136)
Pain (165)
Pancreatic cancer (172)
Parkinson's disease (239)
Partnered (27)
Patents (415)
Patient recruitment (323)
Peanut (57)
People (62564)
Pharmaceutical (84)
Pharmacy benefit managers (27)
Phase I (22335)
Phase II (31581)
Phase III (23669)
Pipeline (2737)
Policy (273)
Postmarket research (2926)
Preclinical (9696)
Press Release (71)
Prostate cancer (200)
Psychedelics (47)
Radiopharmaceuticals (282)
Rare diseases (670)
Real estate (6609)
Recruiting (72)
Regulatory (25821)
Reports (53)
Research institute (2629)
Resumes & cover letters (423)
Rett syndrome (16)
RNA editing (15)
RSV (73)
Schizophrenia (134)
Series A (210)
Series B (158)
Service/supplier (14)
Sickle cell disease (77)
Special edition (25)
Spinal muscular atrophy (165)
Sponsored (37)
Startups (4119)
State (2)
Stomach cancer (17)
Supply chain (96)
Tariffs (89)
The Weekly (74)
Vaccines (1024)
Venture capital (65)
Weight loss (375)
Women's health (57)
Worklife (20)
Date
Today (1)
Last 7 days (728)
Last 30 days (2406)
Last 365 days (31952)
2025 (25783)
2024 (36973)
2023 (41965)
2022 (53282)
2021 (58053)
2020 (56921)
2019 (50273)
2018 (38181)
2017 (35170)
2016 (35387)
2015 (41307)
2014 (35133)
2013 (30601)
2012 (32786)
2011 (33408)
2010 (32057)
Location
Africa (937)
Alabama (73)
Alaska (7)
Arizona (285)
Arkansas (14)
Asia (44441)
Australia (7451)
California (9376)
Canada (2860)
China (896)
Colorado (399)
Connecticut (419)
Delaware (265)
Europe (98748)
Florida (1387)
Georgia (314)
Hawaii (2)
Idaho (65)
Illinois (774)
India (49)
Indiana (450)
Iowa (19)
Japan (325)
Kansas (122)
Kentucky (35)
Louisiana (18)
Maine (68)
Maryland (1269)
Massachusetts (6980)
Michigan (291)
Minnesota (554)
Mississippi (4)
Missouri (120)
Montana (33)
Nebraska (25)
Nevada (108)
New Hampshire (78)
New Jersey (2600)
New Mexico (30)
New York (2567)
North Carolina (1347)
North Dakota (10)
Northern California (4310)
Ohio (288)
Oklahoma (22)
Oregon (41)
Pennsylvania (1966)
Puerto Rico (19)
Rhode Island (45)
South America (1324)
South Carolina (50)
South Dakota (1)
Southern California (3609)
Tennessee (150)
Texas (1454)
United States (34443)
Utah (277)
Virginia (233)
Washington D.C. (81)
Washington State (799)
West Virginia (4)
Wisconsin (85)
Wyoming (1)
782,306 Results for "ra medical systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sponsored
Rosnilimab Shows Promise as a Potential Next-Generation RA Therapy
A depleter of pathogenic T cells, rosnilimab’s novel MOA generated a differentiated efficacy, tolerability and safety profile in recent Phase 2b study
September 15, 2025
·
7 min read
Press Releases
Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA)
October 16, 2025
·
5 min read
Press Releases
Vividion Announces Publication in Science of Preclinical Data on Covalent Inhibitors of RAS-PI3K that Block Tumor Growth
October 9, 2025
·
4 min read
Press Releases
Inspire Medical Systems, Inc. Publishes Inspire V Data at ISSS/AAO-HNS Meetings
October 10, 2025
·
7 min read
Press Releases
ARS Pharmaceuticals Secures Up to $250 Million Loan Facility with RA Capital Management and OMERS Life Sciences to Accelerate U.S. Commercialization of neffy®
September 29, 2025
·
13 min read
Press Releases
Inspire Medical Systems, Inc. to Report Third Quarter 2025 Financial Results on November 3, 2025
October 7, 2025
·
1 min read
Press Releases
Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System
October 22, 2025
·
4 min read
Press Releases
Revolution Medicines and Summit Therapeutics Enter Into Clinical Collaboration to Evaluate Combinations of Three RAS(ON) Inhibitors With Ivonescimab in RAS Mutant Tumors
July 1, 2025
·
13 min read
Press Releases
Inspire Medical Systems, Inc. Announces Departure of Chief Financial Officer
August 26, 2025
·
6 min read
Press Releases
Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Discontinuation of GLP-1RA Therapy
August 13, 2025
·
8 min read
1 of 78,231
Next
